Ombitasvir/paritaprevir/ritonavir and dasabuvir tablets for hepatitis C virus genotype 1 infection. [electronic resource]
Producer: 20150910Description: 566-81 p. digitalISSN:- 1542-6270
- 2-Naphthylamine
- Anilides -- therapeutic use
- Antiviral Agents -- therapeutic use
- Carbamates -- therapeutic use
- Clinical Trials, Phase I as Topic
- Clinical Trials, Phase II as Topic
- Clinical Trials, Phase III as Topic
- Cyclopropanes
- Drug Combinations
- Drug Resistance, Viral
- Drug Therapy, Combination
- Genotype
- Hepacivirus -- genetics
- Hepatitis C, Chronic -- drug therapy
- Humans
- Lactams, Macrocyclic
- Liver Cirrhosis -- drug therapy
- Macrocyclic Compounds -- therapeutic use
- Proline -- analogs & derivatives
- Ribavirin -- therapeutic use
- Ritonavir -- therapeutic use
- Sulfonamides -- therapeutic use
- Tablets
- Uracil -- analogs & derivatives
- Valine
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.